Working… Menu

Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01875653
Recruitment Status : Terminated
First Posted : June 12, 2013
Last Update Posted : May 10, 2019
Information provided by (Responsible Party):
Caladrius Biosciences, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 2016
Actual Study Completion Date : January 2016